Quick Answer
Werewolf Therapeutics, Inc. reported Shares Outstanding of 48.60 million shares for fiscal year 2025.
Werewolf Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 48.60M | +8.4% |
| 2024 | 44.83M | +14.6% |
| 2023 | 39.11M | +24.4% |
| 2022 | 31.43M | +15.1% |
| 2021 | 27.31M | +2206.8% |
| 2020 | 1.18M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 47.27M | +8.1% | +4.3% |
| June 30, 2025 | 45.34M | +3.7% | +1.1% |
| March 31, 2025 | 44.83M | +3.6% | +0.0% |
| December 31, 2024 | 44.83M | +14.6% | +2.5% |
| September 30, 2024 | 43.72M | +22.6% | +0.0% |
| June 30, 2024 | 43.70M | +22.6% | +1.0% |
| March 31, 2024 | 43.28M | +22.6% | +10.7% |
| December 31, 2023 | 39.11M | +24.4% | +9.7% |
- Werewolf Therapeutics, Inc. showed an increase of +8.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Werewolf Therapeutics, Inc.’s shares outstanding has grown by 4004.5% (from 1.18 million shares to 48.60 million shares).
- The most recent figure is from Werewolf Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: